THANK YOU FOR SUBSCRIBING
Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Tech Outlook
THANK YOU FOR SUBSCRIBING
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
With AI at the core, Activ Surgical builds hardware-agnostic surgical software enabling minimally invasive surgical systems (laparoscopes, arthroscopes, and robots) to collaborate with surgeons autonomously. On a mission to enable real-time and best-in-class surgery for everyone, the company has introduced a revolutionary surgical intelligence platform—ActivEdge™— that empowers surgeons to make better-informed decisions, improve patient outcomes, and provide savings to healthcare systems.
Activ Surgical’s first product, ActivSight—a next-gen imaging module—augments any installed visualization system with real-time, intra-operative visual data and images previously invisible to surgeons. “ActivSight can fit into any system, whether a scope or a robot, intra-operatively to deliver key insights to physicians,” says Todd Usen, CEO at Activ Surgical. ActivSight’s overlay technology provides a visual map to the surgical field, making previously invisible functions and critical structures visible to surgeons in a cost-effective and real-time manner. ActivSight is expected to receive its FDA approval and 510(k) clearance at the end of this quarter or early next quarter. The product has already been utilized in 22 successful surgeries in the U.S. and offers multiple benefits to physicians.
ActivInsight, the company’s second product, is an AI and machine learning-based product, which will be designed for continuous improvement and will be underpinned by one of the industry’s largest annotated data sets to be developed by Activ Surgical. As a novel annotation platform, ActivInsight will drastically reduce the time taken for video annotations with an autonomous annotation algorithm, making them nearly 20,000 times faster than traditional surgical video annotation methods.
Activ Surgical has signed a data retrieval and data research contract with one of Asia’s largest healthcare systems, Apollo Hospitals, to annotate surgical datasets. Activ Surgical has also signed agreements with Microsoft, Qualcomm, and Nvidia. As a member of the “Microsoft for Startups” program, Activ Surgical will have exclusive access to Microsoft’s technologies, including Azure, to optimize the storage model. The company is also working with Nvidia to optimize its inference models and Qualcomm for the immediate use of 5G integration and GPU accelerators. Usen notes, “The new contracts have come at an opportune moment for us as we have opened our European headquarters with a full European advisory board comprising world renowned physicians. We are also expecting to receive the CE certification for our products around July this year,” says Usen.
Share this Article:
Tweet
|
Company
Activ Surgical
Headquarters
Boston, MA
Management
Todd Usen, CEO , Activ Surgical
Description
Activ Surgical is a pioneering digital surgery imaging startup that is developing groundbreaking intraoperative surgical intelligence hardware and software. It is building hardware-agnostic surgical software that allows minimally invasive surgical systems (laparoscopes, arthroscopes and robots) to autonomously collaborate with surgeons which will enable surgeons in the operating room to view critical physiological structures and functions, like blood flow, that cannot be seen with the naked eye. The platform will act as the “brain,” enabling applications that have the potential to mitigate surgical error, enhance patient outcomes, and dramatically improve savings to healthcare systems